179 related articles for article (PubMed ID: 23335736)
21. Molecular modelling and simulation studies of the Mycobacterium tuberculosis multidrug efflux pump protein Rv1258c.
Cloete R; Kapp E; Joubert J; Christoffels A; Malan SF
PLoS One; 2018; 13(11):e0207605. PubMed ID: 30475855
[TBL] [Abstract][Full Text] [Related]
22. Reduction of minimum inhibitory concentrations in drug-resistant Mycobacterium tuberculosis isolates in the presence of efflux pump inhibitors.
Yadav R; Dhatwalia SK; Mewara A; Behera D; Sethi S
J Glob Antimicrob Resist; 2016 Jun; 5():88-9. PubMed ID: 27436475
[No Abstract] [Full Text] [Related]
23. Efflux pump effects on
Valıyeva G; Durupınar B; Coban AY
J Chemother; 2023 Nov; 35(7):601-609. PubMed ID: 36718107
[TBL] [Abstract][Full Text] [Related]
24. I3-Ag85 effect on phthiodiolone dimycocerosate synthesis.
Rens C; Laval F; Wattiez R; Lefèvre P; Dufrasne F; Daffé M; Fontaine V
Tuberculosis (Edinb); 2018 Jan; 108():93-95. PubMed ID: 29523333
[TBL] [Abstract][Full Text] [Related]
25. In Silico Approach for Phytocompound-Based Drug Designing to Fight Efflux Pump-Mediated Multidrug-Resistant Mycobacterium tuberculosis.
Biswas SS; Browne RB; Borah VV; Roy JD
Appl Biochem Biotechnol; 2021 Jun; 193(6):1757-1779. PubMed ID: 33826064
[TBL] [Abstract][Full Text] [Related]
26. Discovery of Novel Enhancers of Isoniazid Toxicity in
Lentz F; Reiling N; Martins A; Molnár J; Hilgeroth A
Molecules; 2018 Apr; 23(4):. PubMed ID: 29617279
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of efflux pump genes of Mycobacterium tuberculosis in response to varied subinhibitory concentrations of antituberculosis agents.
Garima K; Pathak R; Tandon R; Rathor N; Sinha R; Bose M; Varma-Basil M
Tuberculosis (Edinb); 2015 Mar; 95(2):155-61. PubMed ID: 25680943
[TBL] [Abstract][Full Text] [Related]
28. Rational Design of Biosafety Level 2-Approved, Multidrug-Resistant Strains of Mycobacterium tuberculosis through Nutrient Auxotrophy.
Vilchèze C; Copeland J; Keiser TL; Weisbrod T; Washington J; Jain P; Malek A; Weinrick B; Jacobs WR
mBio; 2018 May; 9(3):. PubMed ID: 29844114
[TBL] [Abstract][Full Text] [Related]
29. Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs.
Gupta AK; Katoch VM; Chauhan DS; Sharma R; Singh M; Venkatesan K; Sharma VD
Microb Drug Resist; 2010 Mar; 16(1):21-8. PubMed ID: 20001742
[TBL] [Abstract][Full Text] [Related]
30. Clofazimine Exposure
Ismail N; Peters RPH; Ismail NA; Omar SV
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642938
[TBL] [Abstract][Full Text] [Related]
31. Peptidoglycan synthesis in Mycobacterium tuberculosis is organized into networks with varying drug susceptibility.
Kieser KJ; Baranowski C; Chao MC; Long JE; Sassetti CM; Waldor MK; Sacchettini JC; Ioerger TR; Rubin EJ
Proc Natl Acad Sci U S A; 2015 Oct; 112(42):13087-92. PubMed ID: 26438867
[TBL] [Abstract][Full Text] [Related]
32. Molecular modelling and competitive inhibition of a Mycobacterium tuberculosis multidrug-resistance efflux pump.
Scaini JLR; Camargo AD; Seus VR; von Groll A; Werhli AV; da Silva PEA; Machado KDS
J Mol Graph Model; 2019 Mar; 87():98-108. PubMed ID: 30529931
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of Drug-Induced Tolerance in Mycobacterium tuberculosis.
Goossens SN; Sampson SL; Van Rie A
Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055230
[TBL] [Abstract][Full Text] [Related]
34. In vitro combinatory activity of piperine and anti-tuberculosis drugs in Mycobacterium tuberculosis.
Hegeto LA; Caleffi-Ferracioli KR; Nakamura-Vasconcelos SS; Almeida AL; Baldin VP; Nakamura CV; Siqueira VLD; Scodro RBL; Cardoso RF
Tuberculosis (Edinb); 2018 Jul; 111():35-40. PubMed ID: 30029912
[TBL] [Abstract][Full Text] [Related]
35. Mutation of Rv2887, a marR-like gene, confers Mycobacterium tuberculosis resistance to an imidazopyridine-based agent.
Winglee K; Lun S; Pieroni M; Kozikowski A; Bishai W
Antimicrob Agents Chemother; 2015 Nov; 59(11):6873-81. PubMed ID: 26303802
[TBL] [Abstract][Full Text] [Related]
36. MmpS5/MmpL5 as an efflux pump in Mycobacterium species.
Briffotaux J; Huang W; Wang X; Gicquel B
Tuberculosis (Edinb); 2017 Dec; 107():13-19. PubMed ID: 29050760
[TBL] [Abstract][Full Text] [Related]
37. Antituberculosis drugs: reducing efflux=increasing activity.
Rodrigues L; Parish T; Balganesh M; Ainsa JA
Drug Discov Today; 2017 Mar; 22(3):592-599. PubMed ID: 28089787
[TBL] [Abstract][Full Text] [Related]
38. Increased Vancomycin Susceptibility in Mycobacteria: a New Approach To Identify Synergistic Activity against Multidrug-Resistant Mycobacteria.
Soetaert K; Rens C; Wang XM; De Bruyn J; Lanéelle MA; Laval F; Lemassu A; Daffé M; Bifani P; Fontaine V; Lefèvre P
Antimicrob Agents Chemother; 2015 Aug; 59(8):5057-60. PubMed ID: 26033733
[TBL] [Abstract][Full Text] [Related]
39. Coexpression of MmpS5 and MmpL5 Contributes to Both Efflux Transporter MmpL5 Trimerization and Drug Resistance in Mycobacterium tuberculosis.
Yamamoto K; Nakata N; Mukai T; Kawagishi I; Ato M
mSphere; 2021 Jan; 6(1):. PubMed ID: 33408221
[TBL] [Abstract][Full Text] [Related]
40. Deregulation of Genes Associated with Alternate Drug Resistance Mechanisms in Mycobacterium tuberculosis.
Sriraman K; Nilgiriwala K; Saranath D; Chatterjee A; Mistry N
Curr Microbiol; 2018 Apr; 75(4):394-400. PubMed ID: 29143876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
